newli
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
current
spread
among
human
make
develop
effect
mer
vaccin
high
prioriti
defin
receptorbind
domain
rbd
merscov
spike
protein
potenti
serv
subunit
vaccin
candid
merscov
infect
identifi
ideal
vaccin
candid
construct
five
differ
version
rbd
fragment
name
indic
residu
rang
spike
protein
ctermin
fc
tag
investig
receptor
bind
affin
antigen
immunogen
neutral
potenti
result
show
among
rbd
fragment
demonstr
highest
affin
induc
highesttit
igg
antibodi
mice
addit
elicit
highertit
neutral
antibodi
rbd
fragment
mice
also
induc
hightit
neutral
antibodi
immun
rabbit
structur
analysi
suggest
contain
stabli
fold
rbd
structur
full
receptorbind
site
major
neutral
epitop
addit
structur
fragment
introduc
nonneutr
epitop
may
also
alter
tertiari
structur
rbd
taken
togeth
data
suggest
rbd
fragment
encompass
spike
residu
critic
neutral
receptorbind
fragment
ideal
candid
develop
effect
mer
vaccin
ad
nonneutr
structur
rbd
fragment
diminish
neutral
potenti
therefor
viral
vaccin
design
import
identifi
stabl
neutral
viral
rbd
fragment
elimin
unnecessari
nonneutr
structur
mean
immunofocus
emerg
infecti
diseas
middl
east
respiratori
syndrom
mer
caus
mer
coronaviru
merscov
first
identifi
saudi
arabia
sinc
spread
countri
includ
unit
state
juli
laboratoryconfirm
case
includ
death
http
wwwwhointcsrdon
rais
seriou
concern
pandem
potenti
bat
dromedari
camel
like
natur
reservoir
intermedi
transmiss
host
respect
merscov
pose
longterm
threat
human
health
thu
need
develop
effect
prophylact
strategi
vaccin
control
spread
merscov
urgent
spike
protein
merscov
play
import
role
mediat
viral
entri
host
cell
first
step
cell
entri
defin
receptorbind
domain
rbd
spike
protein
bind
function
receptor
dipeptidyl
peptidas
host
cell
surfac
viral
attach
sever
version
merscov
rbd
fragment
identifi
differ
group
rbd
fragment
encompass
spike
residu
respect
extens
studi
found
spike
rbd
sar
coronaviru
sarscov
caus
sar
epidem
critic
neutral
receptorbind
domain
attract
subunit
vaccin
candid
sarscov
infect
like
merscov
rbd
could
also
serv
subunit
vaccin
candid
merscov
infect
inde
previous
shown
merscov
rbd
fragment
immunogen
anim
result
neutral
antibodi
respons
howev
clear
one
rbd
fragment
repres
ideal
vaccin
candid
mechan
behind
potenti
differ
neutral
abil
rbd
fragment
studi
express
merscov
rbd
fragment
fuse
fc
fragment
human
igg
investig
receptor
bind
affin
antigen
immunogen
neutral
potenti
found
rbd
fragment
neutral
potenti
explain
mechan
behind
overal
studi
identifi
ideal
vaccin
candid
control
merscov
infect
enhanc
understand
design
strategi
vial
subunit
vaccin
fourto
sixweekold
femal
balbc
mice
fourto
fivemonthold
femal
nzw
rabbit
use
studi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
approv
committe
ethic
anim
experi
new
york
blood
center
permit
number
construct
express
purif
recombin
merscov
rbd
fragment
fc
human
igg
done
previous
describ
modif
briefli
gene
encod
residu
merscov
protein
respect
amplifi
pcr
use
codonoptim
merscov
sequenc
genbank
templat
insert
express
vector
hereinaft
name
fc
invivogen
san
diego
ca
merscov
residu
plu
ctermin
amplifi
insert
express
vector
jiangsu
taizhou
haiyuan
protein
biotech
co
ltd
china
recombin
plasmid
transfect
cell
atcc
manassa
va
chang
fresh
serumfre
dmem
invitrogen
carlsbad
ca
h
later
collect
supernat
contain
express
protein
h
posttransfect
recombin
protein
purifi
protein
affin
chromatographi
ge
healthcar
piscataway
nj
protein
fc
ninta
superflow
qiagen
valencia
ca
protein
tag
accord
manufactur
instruct
human
ectodomain
residu
express
purifi
previous
describ
briefli
recombin
human
ectodomain
contain
ntermin
honeybe
melittin
signal
peptid
ctermin
express
insect
cell
use
bactobac
express
system
invitrogen
secret
cell
cultur
medium
subsequ
purifi
ninta
affin
column
gel
filtrat
column
ge
healthcar
purifi
merscov
rbd
fragment
analyz
sdspage
western
blot
previous
describ
briefli
boil
nonboil
protein
separ
trisglycin
sdspage
gel
follow
transfer
nitrocellulos
membran
block
overnight
use
nonfat
milk
pbst
blot
incub
h
room
temperatur
merscov
sspecif
polyclon
antibodi
three
wash
blot
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
invitrogen
h
room
temperatur
signal
visual
use
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
bind
merscov
rbd
fragment
perform
coimmunoprecipit
assay
previous
describ
briefli
recombin
solubl
cell
lysat
ml
respect
incub
merscov
rbd
fragment
plu
protein
sepharos
bead
h
follow
wash
lysi
buffer
pb
boil
min
sampl
subject
sdspage
western
blot
analysi
follow
detect
use
monoclon
antibodi
r
system
minneapoli
mn
merscov
polyclon
antibodi
respect
mice
immun
merscov
rbd
fragment
follow
previous
describ
protocol
briefli
mice
primevaccin
subcutan
sc
mous
recombin
merscov
rbd
fragment
presenc
montanid
isa
adjuv
seppic
fairfield
nj
boost
twice
immunogen
adjuv
day
interv
sera
day
postlast
vaccin
day
heatinactiv
minut
detect
merscov
sspecif
antibodi
respons
neutral
antibodi
sera
day
postiniti
immun
also
test
merscov
sspecif
antibodi
respons
rabbit
immun
covanc
research
product
inc
denver
pa
follow
protocol
similar
mice
modif
briefli
rabbit
primevaccin
merscov
fragment
plu
freund
complet
adjuv
boost
twice
interv
immunogen
plu
freund
incomplet
adjuv
sera
collect
test
elisa
carri
test
bind
merscov
rbd
fragment
previous
describ
briefli
elisa
plate
precoat
overnight
block
nonfat
milk
h
dilut
merscov
rbd
fragment
ad
plate
incub
h
follow
four
wash
bound
antibodi
incub
hrpconjug
antihuman
igg
invitrogen
h
reaction
visual
substrat
tmb
invitrogen
stop
h
absorb
nm
measur
elisa
plate
reader
tecan
san
jose
ca
detect
merscov
sspecif
antibodi
respons
collect
mous
sera
perform
follow
protocol
similar
describ
except
replac
coat
antigen
merscov
protein
primari
antibodi
serial
dilut
mous
sera
secondari
antibodi
antimous
igghrp
invitrogen
standard
microneutr
assay
use
quantifi
neutral
potenti
rbd
fragment
previous
describ
briefli
serum
sampl
dilut
serial
tissu
cultur
plate
incub
h
room
temperatur
infecti
transfer
duplic
well
vero
cell
grown
tissu
cultur
plate
h
incub
viru
control
well
exhibit
advanc
virusinduc
cytopath
effect
cpe
neutral
capac
individu
serum
sampl
assess
determin
presenc
absenc
cpe
neutral
antibodi
titer
express
reciproc
highest
dilut
serum
complet
inhibit
virusinduc
cpe
least
well
nt
valu
present
mean
standard
deviat
sd
statist
signific
among
differ
vaccin
group
calcul
student
ttest
use
stata
statist
softwar
p
valu
less
consid
statist
signific
five
human
igg
fcfuse
fragment
repres
defin
rbd
residu
merscov
spike
protein
rbd
residu
control
construct
express
subject
antigen
measur
use
procedur
previous
describ
five
rbd
fragment
express
high
level
cultur
supernat
transfect
cell
purifi
high
homogen
ctermin
fc
tag
strongli
promot
format
rbd
dimer
evidenc
almost
twice
molecular
weight
nondenatur
versu
denatur
protein
fig
top
recombin
rbd
fragment
react
strongli
polyclon
antibodi
specif
rais
mice
recombin
protein
merscov
fig
bottom
suggest
nativ
antigen
conform
two
altern
assay
coimmunoprecipit
elisa
carri
measur
receptorbind
activ
merscov
rbd
fragment
result
coimmunoprecipit
assay
show
five
merscov
rbd
fragment
coimmunoprecipit
recombin
protein
two
clear
band
correspond
size
respect
fcfuse
merscov
rbd
fragment
readili
reveal
antimerscov
antibodi
wherea
singl
band
molecular
weight
correspond
detect
sampl
contain
fig
left
addit
five
merscov
rbd
fragment
coimmunoprecipit
cellassoci
anchor
cell
target
protein
anticip
size
identifi
use
antimerscov
antibodi
respect
fig
right
thu
coimmunoprecipit
assay
demonstr
five
rbd
fragment
specif
interact
merscov
receptor
elisa
perform
ad
merscov
rbd
fragment
plate
coat
fix
amount
follow
identif
bind
affin
base
od
valu
nm
test
merscov
rbd
capabl
bind
note
exist
differenti
bind
capac
shown
figur
among
five
rbd
fragment
possess
significantli
higher
affin
concentr
respect
expect
control
higgfc
protein
show
specif
bind
fig
therefor
extend
cterminu
merscov
rbd
fragment
appear
neg
effect
receptorbind
activ
evalu
immunogen
five
merscov
rbd
fragment
immun
mice
rbd
fragment
accord
dose
strategi
describ
materi
method
detect
specif
respons
total
igg
antibodi
along
subtyp
serum
specimen
immun
mice
elisa
result
show
five
rbd
fragment
immunogen
mice
induc
product
igg
antibodi
specif
bind
merscov
protein
without
fusion
fc
particularli
sera
mice
immun
acquir
stronger
bind
merscov
protein
immun
three
rbd
fragment
wherea
control
sampl
pbsimmun
mice
reveal
neglig
bind
activ
fig
confirm
specif
igg
antibodi
respons
elicit
rbd
fragment
addit
endpoint
titrat
igg
antibodi
respons
reveal
immunogen
elicit
merscov
igg
antibodi
mice
vaccin
fig
thu
extend
cterminu
merscov
rbd
also
reduc
immunogen
rbd
fragment
observ
igg
subtyp
reveal
capabl
induc
significantli
higher
level
antibodi
respons
elicit
antibodi
significantli
higher
fig
addit
promot
significantli
higher
level
antibodi
respons
wherea
antibodi
induc
also
significantli
higher
induc
respect
fig
result
suggest
among
rbd
fragment
induc
high
titer
antibodi
respons
neutral
potenti
five
rbd
fragment
initi
evalu
immun
mice
result
vero
microneutr
show
five
rbd
fragment
capabl
induc
neutral
antibodi
among
induc
highest
level
neutral
antibodi
respons
th
day
third
immun
fig
expect
sera
pbsimmun
mice
show
neutral
activ
thu
highest
neutral
potenti
among
five
rbd
fragment
furthermor
use
immun
rabbit
confirm
neutral
potenti
differ
anim
speci
vero
microneutr
assay
demonstr
th
day
third
immun
high
titer
neutral
antibodi
respons
gener
rabbit
fig
therefor
shortest
among
five
rbd
fragment
produc
hightit
neutral
antibodi
respons
mice
rabbit
suggest
fragment
contain
residu
merscov
spike
protein
critic
neutral
receptorbind
domain
elucid
potenti
vaccin
candid
immun
mice
protein
period
day
observ
kinet
antibodi
respons
expect
increas
titer
igg
antibodi
found
mous
sera
initi
immun
reach
highest
titer
day
postimmun
antibodi
titer
decreas
slightli
afterward
still
maintain
rel
high
level
fig
data
demonstr
fragment
contain
residu
merscov
spike
protein
abl
induc
maintain
rbdspecif
immun
respons
vaccin
anim
least
four
month
confirm
good
potenti
develop
subunit
mer
vaccin
increas
number
mer
case
indic
urgenc
develop
effect
vaccin
merscov
infect
diseas
among
merscov
structur
protein
spike
protein
particularli
rbd
import
target
effort
due
proven
abil
elicit
potent
neutral
antibodi
respons
immun
laboratori
anim
inde
recombin
rbd
fragment
contain
residu
merscov
shown
induc
neutral
antibodi
respons
immun
rabbit
mice
respect
moreov
modifi
vaccinia
viru
ankara
mva
express
fulllength
protein
merscov
also
proven
effect
vaccin
mice
produc
potent
neutral
antibodi
restrict
merscov
infect
vivo
addit
aforement
recombin
protein
viral
vector
nanoparticl
venezuelan
equin
enceph
viru
replicon
particl
vrp
express
spike
protein
merscov
also
shown
great
potenti
mer
vaccin
studi
express
five
differ
version
merscov
rbd
fragment
base
previous
publish
studi
investig
compar
receptor
bind
abil
antigen
immunogen
neutral
potenti
fc
human
igg
fuse
rbd
fragment
fc
tag
enhanc
express
purif
immunogen
viral
rbd
protein
result
show
abil
rbd
fragment
induc
immun
respons
neutral
antibodi
differ
significantli
among
rbd
fragment
demonstr
high
receptorbind
affin
induc
high
titer
igg
antibodi
mice
elicit
highest
titer
neutral
antibodi
mice
also
induc
high
titer
neutral
antibodi
rabbit
crystal
structur
merscov
rbd
reveal
rbd
fragment
encompass
residu
merscov
spike
protein
stabli
fold
structur
order
residu
nand
ctermini
contain
receptorbind
motif
rbm
residu
fig
almost
major
neutral
epitop
identifi
merscov
rbd
mani
specif
recogn
neutral
monoclon
antibodi
nab
epitop
cluster
protrud
ridg
rbm
region
rbd
overlap
site
fig
although
yet
experiment
confirm
region
rbm
overlap
site
may
also
contain
neutral
epitop
hand
region
merscov
spike
overlap
site
like
contain
nonneutr
epitop
nonneutr
epitop
might
hinder
product
neutral
antibodi
may
also
induc
harm
immun
respons
region
rbd
core
structur
contribut
fold
stabil
whole
rbd
thu
essenti
howev
region
flank
rbd
contribut
protein
fold
receptor
bind
therefor
necessari
identifi
critic
neutral
epitop
rbd
merscov
spike
protein
exclud
nonneutr
epitop
without
expens
domain
integr
stabil
mean
immunofocus
vaccin
develop
import
test
immun
efficaci
anim
model
challeng
merscov
nonhuman
primat
rhesu
macaqu
infect
merscov
show
clinic
sign
diseas
histopatholog
chang
lung
howev
high
cost
purchas
maintain
monkey
perform
experi
facil
prevent
us
use
anim
model
small
anim
mice
syrian
hamster
ferret
infect
sarscov
unsuscept
merscov
infect
although
mice
transduc
adenovir
vector
express
human
infect
merscov
show
signific
clinic
symptom
mer
therefor
vivo
efficaci
merscov
rbdbase
vaccin
candid
evalu
sophist
small
anim
model
becom
avail
overal
rbd
fragment
encompass
residu
merscov
protein
ideal
subunit
vaccin
candid
capabl
induc
strong
neutral
antibodi
differ
speci
anim
therefor
focu
futur
develop
mer
vaccin
furthermor
studi
suggest
vaccin
design
mayb
help
elimin
nonneutr
epitop
rbd
fragment
keep
rbd
fragment
physiolog
relev
conform
also
allow
host
immun
respons
focu
neutral
epitop
coimmunoprecipit
assay
follow
western
blot
analys
perform
determin
bind
affin
rbd
fragment
receptor
briefli
purifi
recombin
rbd
fragment
incub
either
left
cell
right
presenc
protein
sepharos
bead
subject
western
blot
analysi
either
top
antimerscov
antibodi
bottom
b
elisa
carri
measur
bind
affin
rbd
fragment
recombin
recombin
human
igg
fc
higgfc
protein
includ
neg
control
signific
differ
three
rbd
fragment
two
respect
sera
collect
day
postlast
immun
rbd
fragment
subject
immunogen
studi
serum
specimen
shampbsimmun
mice
includ
neg
control
data
present
mean
sd
five
mice
group
total
igg
antibodi
specif
merscov
protein
assess
elisa
b
merscov
igg
antibodi
elicit
group
differenti
immun
mice
determin
elisa
titer
express
endpoint
dilut
remain
posit
detect
signific
differ
two
rbd
fragment
three
c
merscov
subtyp
antibodi
titer
group
mice
immun
indic
rbd
fragment
compar
base
endpoint
analysi
elisa
signific
differ
three
rbd
fragment
two
rbd
fragment
endpoint
titer
merscov
subtyp
antibodi
deriv
mice
immun
differ
rbd
fragment
compar
signific
differ
four
rbd
fragment
three
rbd
fragment
respect
aforement
serum
specimen
subject
vero
microneutr
assay
live
merscov
infect
neutral
antibodi
titer
express
reciproc
highest
dilut
specimen
test
result
complet
inhibit
virusinduc
cpe
least
well
nt
neutral
antibodi
titer
sera
mice
immun
merscov
rbd
fragment
sera
day
rd
immun
use
test
data
present
mean
sd
five
mice
group
signific
differ
four
rbd
fragment
b
neutral
antibodi
titer
sera
rabbit
immun
protein
sera
preimmun
day
rd
immun
use
test
data
present
mean
sd
duplic
well
c
endpoint
titer
merscov
igg
antibodi
elisa
mous
sera
day
postimmun
data
present
mean
sd
five
mice
group
merscov
spike
rbd
wellfold
structur
contain
core
structur
blue
receptorbind
motif
rbm
magenta
helic
drawn
cylind
strand
arrow
crystal
rbd
fragment
encompass
residu
nand
cterminu
label
n
c
respect
ntermin
region
rbd
fragment
residu
disord
indic
dash
line
neutral
epitop
recogn
known
nab
indic
rbm
